Biolty SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Biolty SL - overview
Location
Madrid, -, Spain
Primary Industry
Business Support Services
About
Based in Madrid Spain, Biolty SL operates as a provider of business management consulting services.
Primary Industry
Business Support Services
Sub Industries
Consulting Services, Investment Banking
Website
www.biolty.com
Total Amount Raised
Subscriber access only
Biolty SL - timeline of key events

Biolty SL - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 676,445.5 | 434,745.7 | 364,899.8 | 272,265.4 | 281,345 | 221,163.4 | 208,000 | - | - | - |
| % Revenue Growth (YoY) | - | (35.7%) | (16.1%) | (25.4%) | 3.3% | (21.4%) | (6.0%) | - | - | - |
| EBITDA (USD) | 100,814.9 | 61,971.7 | 53,461.5 | 72,661.7 | 70,741.1 | 63,494.6 | 66,296.9 | - | - | - |
| Operating Income (USD) | 70,938.7 | 43,583.9 | 49,589.8 | 69,379.2 | 67,458.6 | 60,752 | 42,734.4 | - | - | - |
| Operating Margin | 10.5% | 10.0% | 13.6% | 25.5% | 24.0% | 27.5% | 20.5% | - | - | - |
| % EBITDA Margin | 14.9% | 14.3% | 14.7% | 26.7% | 25.1% | 28.7% | 31.9% | - | - | - |
| NET Income (USD) | 50,621.1 | 30,130.7 | 31,880.1 | 49,828.1 | 48,527 | 42,067.9 | 28,203 | - | - | - |
| % Net Margin | 7.5% | 6.9% | 8.7% | 18.3% | 17.2% | 19.0% | 13.6% | - | - | - |
Biolty SL - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Instituto de Medicina Genómica, S.L. | - | ||||||||
| Buyout | Completed | Instituto de Medicina Genómica, S.L. | - |
Displaying 1 - 2 of 2
Biolty SL - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.